Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

J&J gets EMA nod for wider use of Erleada in prostate cancer

Maintains a regulatory lead over rival Xtandi

- PMLiVE

New faces at Synergy Vision, Makara Health and JPA Health

The latest movers in healthcare comms

- PMLiVE

Policy and public health: patient preferences

When selecting a healthcare provider, what patients are looking for can reveal a lot

OPEN Health’s response to the FDA’s guidance on long term follow up post gene therapy

Written by Gavin Jones, OPEN Health

OPEN Health

- PMLiVE

Four Comms restructures, reveals 2019 revenue growth and acquisition plan

Four Communications has undergone a restructure, with 17 practices reorganised into seven business units - as the firm reveals that revenue grew eight per cent in 2019. It is also...

Four Agency Worldwide

- PMLiVE

Vyndaqel a bright spot as Pfizer comes under pressure

Faces a challenging period as big brands experience a slowdown

- PMLiVE

Troubled Alkermes eyes November OK for new antipsychotic

Review begins for potential schizophrenia and bipolar I disorder drug

- PMLiVE

EMA begins review of Kite’s CAR-T for mantle cell lymphoma

If approved will become first CAR-T therapy for MCL

Novartis day

Cosentyx, Entresto drive topline growth for Novartis in Q4

Overall net income fell for the full year compared to 2018

- PMLiVE

Havas Health & You expands leadership team

Philippe Huot-Louradour joins as EU technology & innovation lead

- PMLiVE

Creating a culture where innovation thrives

It starts with us

- PMLiVE

Acceleron rockets on positive mid-stage pulmonary arterial hypertension data

Sotatercept hit primary and all secondary endpoints

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links